Magnetic Resonance Imaging Conditionally Safe Neurostimulation Leads

Neurosurgery ◽  
2013 ◽  
Vol 74 (2) ◽  
pp. 215-225 ◽  
Author(s):  
Robert J. Coffey ◽  
Ron Kalin ◽  
James M. Olsen

Abstract BACKGROUND: Magnetic resonance imaging (MRI) is preferred for imaging the central nervous system (CNS). An important hazard for neurostimulation patients is heating at the electrode interface induced, for example, by 64-MHz radiofrequency (RF) magnetic fields of a 1.5T scanner. OBJECTIVE: We performed studies to define the thermal dose (time and temperature) that would not cause symptomatic neurological injury. METHODS: Approaches included animal studies where leads with temperature probes were implanted in the brain or spine of sheep and exposed to RF-induced temperatures of 37°C to 49°C for 30 minutes. Histopathological examinations were performed 7 days after recovery. We also reviewed the threshold for RF lesions in the CNS, and for CNS injury from cancer hyperthermia. Cumulative equivalent minutes at 43°C was used to normalize the data to exposure times and temperatures expected during MRI. RESULTS: Deep brain and spinal RF heating up to 43°C for 30 minutes produced indistinguishable effects compared with 37°C controls. Exposures greater than 43°C for 30 minutes produced temperature-dependent, localized thermal damage. These results are consistent with limits on hyperthermia exposure to 41.8°C for 60 minutes in patients who have cancer and with the reversibility of low-temperature and short-duration trial heating during RF lesion procedures. CONCLUSION: A safe temperature for induced lead heating is 43°C for 30 minutes. MRI-related RF heating above 43°C or longer than 30 minutes may be associated with increased risk of clinically evident thermal damage to neural structures immediately surrounding implanted leads. The establishment of a thermal dose limit is a first step toward making specific neurostimulation systems conditionally safe during MRI procedures.

Cardiology ◽  
2018 ◽  
Vol 140 (4) ◽  
pp. 227-236 ◽  
Author(s):  
Fabien Huet ◽  
Mariama Akodad ◽  
Nils Kuster ◽  
Hélène Kovacsik ◽  
Florence Leclercq ◽  
...  

Introduction: Micro-vascular occlusion (MVO) in a myocardial infarction (MI) is associated with an increased risk of heart failure and mortality. Hs-T-troponin has a double peak kinetic after MI. The aim was to determine if this kinetic was correlated to MVO evaluated by cardiac magnetic resonance imaging (MRI) after MI. Methods: This is a monocentric retrospective study. Inclusion criteria were hospitalization for MI, Thrombolysis In Myocardial Infarction flow 0 at coronary angiography, reperfusion within 12 h from the onset of chest pain, cardiac MRI within the first month, and a 5-days’ biological follow-up with at least hs-T-Troponin and C-reactive protein (CRP). Statistics were performed using the R software. Results: Ninety-eight patients were included. Fifty-three patients (54.1%) had MVO at MRI. The existence of MVO was associated with a trend of more kissing procedure during primary percutaneous coronary intervention (p = 0.06), a significantly more frequent second peak of troponin (p = 0.048), a significantly higher CRP level (p < 0.0001) and a longer time to balloon (p = 0.01). The association of CRP level above 40 mg/L at day 2 and the observation of a second peak of troponin were associated to 95% of MVO in ST-segment elevation MI patients. By contrast, in the absence of these 2 criteria, MVO was absent in 78% of the cases. This score was associated with a higher rate of hospitalisation at 2 years. Conclusion: A biological score integrating hs-TNT second peak and CRP might help to predict MVO and predict outcomes after reperfused MI in our population.


Author(s):  
N.D. Scollan ◽  
L.J. Caston ◽  
Z. Liu ◽  
A.K. Zubair ◽  
S. Leeson ◽  
...  

In studies of animal growth it is often necessary to assess whole body composition or organ size prior to and during the course of a particular treatment. Nuclear Magnetic Resonance (NMR) offers the possibility to achieve these measurements on the same animal and in a non-invasive fashion. The use of NMR in attaining body images, referred to as Magnetic Resonance Imaging (MRI), has developed as the imaging method of choice for humans, due to its excellent soft tissue contrast and use of nonionizing radiation. The use of NMR in animal studies has been limited, which is probably related to the availability of suitable facilities and the cost of using them. However, several research groups have applied it to determining fat and water content of tissue samples and intact animals (Mitchell et al., 1991; Scollan et al., 1993). The aim of this study was to evaluate the use of MRI to determine the size (volume) and shape of the Pectoralis muscle (Pectoralis major and minor) in broiler chickens, non-invasively and in vivo.


2014 ◽  
Vol 66 (7) ◽  
pp. 1811-1819 ◽  
Author(s):  
Leena Sharma ◽  
Joan S. Chmiel ◽  
Orit Almagor ◽  
Dorothy Dunlop ◽  
Ali Guermazi ◽  
...  

2016 ◽  
Vol 43 (9) ◽  
pp. 1704-1712 ◽  
Author(s):  
Jürgen Braun ◽  
Xenofon Baraliakos ◽  
Kay-Geert A. Hermann ◽  
Stephen Xu ◽  
Benjamin Hsu

Objective.Serum C-reactive protein (CRP) associates with radiographic progression in patients with ankylosing spondylitis (AS) untreated with tumor necrosis factor (TNF) antagonists. We assessed correlations between serum CRP and radiographic progression/magnetic resonance imaging (MRI)-detected inflammation after 2 years of anti-TNF therapy.Methods.Patients with active AS receiving golimumab (GOL)/placebo through Week 16 (early escape) or Week 24 (crossover by design), followed by GOL through 4 years, had sera/images obtained through Week 208. Lateral spinal radiographs and spinal MRI were scored with the modified Stoke AS Spine Score (mSASSS) and the AS spine MRI activity (ASspiMRI-a) score, respectively. ANOVA assessed differences based on CRP levels and mSASSS progression. The relationships between CRP levels and mSASSS/ASspiMRI-a were assessed by Spearman correlation and logistic regression.Results.Of the randomized GO-RAISE patients, 299 (84.0%) had pre- and posttreatment spinal radiographs. Larger proportions of patients with Week 104 CRP ≥ 0.5 mg/dl (n = 47) versus < 0.5 mg/dl (n = 236, 40.4% vs 22.9%, p = 0.0121) had mSASSS changes ≥ 2 at Week 104. Across several visits, serum CRP demonstrated weak associations with mSASSS change (rs ≤ 0.21, p < 0.05, n = 262–293) and moderate associations with ASspiMRI-a change (rs = −0.33 to 0.54, p < 0.05, n = 65–89). Higher baseline CRP was associated with increased risk for syndesmophytes at Week 104/Week 208, and large, short-term decreases in CRP from baseline to Week 14/Week 24 also yielded increased syndesmophyte formation risk.Conclusion.Elevated CRP after 2 years of anti-TNF treatment correlated with greater radiographic progression risk at 4 years. Elevated CRP at baseline or Week 14/Week 24 of anti-TNF treatment weakly predicted subsequent radiographic progression and modestly predicted residual spinal inflammation in patients with AS treated with anti-TNF. Findings are useful regarding new treatment options in patients treated with anti-TNF. ClinicalTrials.gov: NCT00265083.


Sign in / Sign up

Export Citation Format

Share Document